{
  "id": 561,
  "text": "6 1 \\$ ( $9 5 \\%$ CI = 0.42-0.89).The authors also mentionned that NACT decreased the need for adjuvant radiotherapy when compared with primary surgical treatment ( $\\mathrm { \\Delta O R } \\ : = \\ : 0 .",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 6 1 \\$ ( $9 5 \\%$ CI = 0.42-0.89).The authors also mentionned that NACT decreased the need for adjuvant radiotherapy when compared with primary surgical treatment ( $\\mathrm { \\Delta O R } \\ : = \\ : 0 .\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "新辅助化疗（NACT）在宫颈癌治疗中能够减少术后辅助放疗的需求，这与主要手术治疗相比是其显著的优势之一。这是因为新辅助化疗通过缩小肿瘤体积，降低病灶范围，从而在手术后降低术后病理因素导致的辅助放疗指征的可能性。这种治疗方法在某些情况下还可以提高患者的保育性治疗效果和生活质量。\n\n相较于主要手术治疗，新辅助化疗的差异在于治疗模式的不同。NACT在手术前应用化疗药物，以期取得瘤体降期效果并改善局部控制，而主要手术治疗则多倾向于直接依赖外科手术对原发病灶和周边病灶的切除。由此可见，新辅助化疗可以优化治疗策略，降低部分术后并发症风险，并减少综合治疗时间和经济负担等方面的压力。\n\n综合考虑患者的肿瘤分期、全身健康状况以及多学科团队建议，选择适当的治疗模式对提高宫颈癌的疗效具有重要意义。",
  "query": "新辅助化疗在宫颈癌治疗中如何影响辅助放疗的需求，相较于主要的手术治疗有哪些差异？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 新辅助化疗在宫颈癌治疗中如何影响辅助放疗的需求，相较于主要的手术治疗有哪些差异？\n\n<reference text>: 6 1 \\$ ( $9 5 \\%$ CI = 0.42-0.89).The authors also mentionned that NACT decreased the need for adjuvant radiotherapy when compared with primary surgical treatment ( $\\mathrm { \\Delta O R } \\ : = \\ : 0 .\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "新辅助化疗（NACT）在宫颈癌治疗中能够减少术后辅助放疗的需求，这与主要手术治疗相比是其显著的优势之一。这是因为新辅助化疗通过缩小肿瘤体积，降低病灶范围，从而在手术后降低术后病理因素导致的辅助放疗指征的可能性。这种治疗方法在某些情况下还可以提高患者的保育性治疗效果和生活质量。\n\n相较于主要手术治疗，新辅助化疗的差异在于治疗模式的不同。NACT在手术前应用化疗药物，以期取得瘤体降期效果并改善局部控制，而主要手术治疗则多倾向于直接依赖外科手术对原发病灶和周边病灶的切除。由此可见，新辅助化疗可以优化治疗策略，降低部分术后并发症风险，并减少综合治疗时间和经济负担等方面的压力。\n\n综合考虑患者的肿瘤分期、全身健康状况以及多学科团队建议，选择适当的治疗模式对提高宫颈癌的疗效具有重要意义。"
}